Aiello Bowles EJ, Ramin C, Vo JB, Feigelson HS, Gander JC, Veiga LHS, Bodelon C, Curtis RE, Brandt C, Berrington de Gonzalez A, Gierach GL. Endocrine therapy initiation among women diagnosed with ductal carcinoma in situ from 2001-2018. Breast Cancer Res Treat. 2024 Aug 16. doi: 10.1007/s10549-024-07453-0. Online ahead of print. PubMed

Abrahão R, Brunson A, Chubak J, Wernli KJ, Nichols HB, Chao C, Ruddy KJ, Hahn EE, Li Q, Malogolowkin MH, Sauder CAM, Kushi LH, Wun T, Keegan THM. Late venous thromboembolism in survivors of adolescent and young adult cancer: A population-based study in California.  Thromb Res. 2024;235:1-7. doi: 10.1016/j.thromres.2024.01.002. Epub 2024 Jan 15.  PubMed

Abrahão R, Brunson A, Ruddy KJ, Li Q, Li J, Ryder MM, Chubak J, Nichols HB, Sauder CAM, Gray MF, Hahn EE, Wun T, Keegan THM. Late endocrine diseases in survivors of adolescent and young adult cancer in California: a population-based study. Br J Cancer. 2024 Feb 8. doi: 10.1038/s41416-024-02594-x. [Epub ahead of print]. PubMed

Alimena S, Lykken JM, Tiro JA, Chubak J, Haas JS, Werner C, Kobrin SC, Silver MI, Perkins RB, Feldman S. Accessibility of criteria to exit cervical cancer screening at age 65 years in the electronic health record. O G Open. 1(3):p 032, September 2024. | DOI: 10.1097/og9.0000000000000035. [Epub 19 Sept 2024]. PubMed

Allison BA, Vear K, Hoopes AJ, Maslowsky J. The perceived impact of a post-Dobbs landscape on U.S. adolescents and young adults.  Contraception. 2024 Jun 13:110513. doi: 10.1016/j.contraception.2024.110513 [Epub ahead of print] PubMed